
Atherosclerosis is a major contributor to an ischemic heart attack. Immune cells are recognized as important players in plaque instability; however, multipotent γδ-T cells are rarely investigated. The present study aims to define their role and the therapeutic potential of targeting them in atherosclerosis. The studies have shown that bone marrow-derived CD27-positive γδ-T cells are key players in atherosclerosis by contributing to lesion cytotoxicity and inflammation via both direct and indirect effector functions. These findings provide proof-of-concept data that may ultimately lead to a novel therapeutic strategy that can prevent plaque rupture and significantly reduce ischemic heart attack.
Like
Save
Share